Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07564141
Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Phase 3 · Czechia, Germany, Spain, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, United States · 90 sites
Registry update: 4 Nov 2026
NCT07778316
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Phase 3 · Australia, Switzerland, China, Japan, United States · 9 sites
Registry update: 17 Sept 2026
NCT07802769
Recruiting
Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma
Not applicable · France · 1 site
Registry update: 3 Sept 2026
NCT07640789
Recruiting
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)
Phase 3 · China · 1 site
Registry update: 10 Sept 2026
NCT07412262
Recruiting
A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression
Phase 2 · China · 2 sites
Registry update: 25 Aug 2026
NCT07718243
Recruiting
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
Phase 1/2 · United Kingdom · 2 sites
Registry update: 8 Sept 2026
NCT07743450
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Phase 3 · Czechia, Germany, United Kingdom, Greece, Poland, United States · 117 sites
Registry update: 16 Sept 2026
NCT07708961
Recruiting
Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
Phase 2 · United States · 3 sites
Registry update: 26 Oct 2026
NCT07766226
Recruiting
Online Sharing for Head & Neck Cancer Support
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07705555
Recruiting
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Phase 3 · Argentina, Australia, United Kingdom, United States · 35 sites
Registry update: 3 Nov 2026
NCT07229482
Recruiting
Potatoes, Type 2 Diabetes, and Cardiometabolic Health
Not applicable · United States · 1 site
Registry update: 3 Sept 2026
NCT07768397
Recruiting
Accelerated Versus Standard Intermittent Theta Burst Stimulation for Major Depressive Disorder
Not applicable · Vietnam · 1 site
Registry update: 9 Sept 2026
NCT07337577
Recruiting
Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
Not applicable · United States · 1 site
Registry update: 31 Aug 2026
NCT07908563
Recruiting
Dupilumab in Major Depressive Disorder
Phase 2 · United States · 1 site
Registry update: 2 Nov 2026
NCT07780643
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1)
Phase 3 · United States · 1 site
Registry update: 25 Sept 2026
NCT07137104
Recruiting
Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease
Phase 1/2 · Taiwan · 1 site
Registry update: 29 Sept 2026
2025-524335-39-00
Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Phase 3 · Germany, Spain, France, Italy, Netherlands, Poland · 40 sites
Registry update: 27 Jul 2026
NCT07448610
Recruiting
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Phase 4 · United States · 6 sites
Registry update: 29 Oct 2026
NCT07783802
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Phase 2 · Argentina, Japan, Puerto Rico, United States · 46 sites
Registry update: 3 Nov 2026
2025-524793-42-00
Recruiting
Phase 2 Randomized, Double-blind, Placebo-controlled Study of Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma
Phase 2 · Spain, France, Greece, Hungary, Portugal, Sweden · 37 sites
Registry update: 11 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.